Следене
Jerome Zoidakis
Jerome Zoidakis
Research Scientist, Biomedical Research Foundation, Academy of Athens
Потвърден имейл адрес: bioacademy.gr
Заглавие
Позовавания
Позовавания
Година
Expression and characterization of 1-aminocyclopropane-1-carboxylate deaminase from the rhizobacterium Pseudomonas putida UW4: a key enzyme in bacterial …
N Hontzeas, J Zoidakis, BR Glick, MM Abu-Omar
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1703 (1), 11-19, 2004
1582004
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
H Mischak, W Kolch, M Aivaliotis, D Bouyssié, M Court, H Dihazi, ...
Proteomics–Clinical Applications 4 (4), 464-478, 2010
1382010
Profilin 1 is a potential biomarker for bladder cancer aggressiveness
J Zoidakis, M Makridakis, PG Zerefos, V Bitsika, S Esteban, M Frantzi, ...
Molecular & cellular proteomics 11 (4), 2012
1192012
Modular structure, local flexibility and cold-activity of a novel chitobiase from a psychrophilic Antarctic bacterium
T Lonhienne, J Zoidakis, CE Vorgias, G Feller, C Gerday, V Bouriotis
Journal of molecular biology 310 (2), 291-297, 2001
1072001
Comparative analysis of label-free and 8-Plex iTRAQ approach for quantitative tissue proteomic analysis
A Latosinska, K Vougas, M Makridakis, J Klein, W Mullen, M Abbas, ...
PloS one 10 (9), e0137048, 2015
952015
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center StudyDevelopment of Urinary Biomarker Panels for Bladder Cancer
M Frantzi, KE Van Kessel, EC Zwarthoff, M Marquez, M Rava, N Malats, ...
Clinical Cancer Research 22 (16), 4077-4086, 2016
862016
An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion
A Hatzioannou, A Banos, T Sakelaropoulos, C Fedonidis, MS Vidali, ...
Nature immunology 21 (1), 75-85, 2020
672020
Order of substrate binding in bacterial phenylalanine hydroxylase and its mechanistic implication for pterin-dependent oxygenases
A Volner, J Zoidakis, MM Abu-Omar
JBIC Journal of Biological Inorganic Chemistry 8 (1), 121-128, 2003
612003
Proteomics and metabolomics for AKI diagnosis
D Marx, J Metzger, M Pejchinovski, RB Gil, M Frantzi, A Latosinska, ...
Seminars in nephrology 38 (1), 63-87, 2018
592018
SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine
G Mermelekas, A Vlahou, J Zoidakis
Expert review of molecular diagnostics 15 (11), 1441-1454, 2015
502015
Comparison of depletion strategies for the enrichment of low-abundance proteins in urine
S Filip, K Vougas, J Zoidakis, A Latosinska, W Mullen, G Spasovski, ...
PLoS One 10 (7), e0133773, 2015
442015
Evaluation of decellularization in umbilical cord artery
P Mallis, I Gontika, T Poulogiannopoulos, J Zoidakis, A Vlahou, ...
Transplantation proceedings 46 (9), 3232-3239, 2014
372014
Cervical cancer cell line secretome highlights the roles of transforming growth factor-beta-induced protein ig-h3, peroxiredoxin-2, and NRF2 on cervical carcinogenesis
G Kontostathi, J Zoidakis, M Makridakis, V Lygirou, G Mermelekas, ...
BioMed research international 2017, 2017
362017
Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring
G Kontostathi, J Zoidakis, NP Anagnou, KI Pappa, A Vlahou, M Makridakis
Expert review of proteomics 13 (8), 731-745, 2016
342016
Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
V Lygirou, A Latosinska, M Makridakis, W Mullen, C Delles, JP Schanstra, ...
Journal of Translational Medicine 16 (1), 1-12, 2018
332018
New selective peptidyl di (chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases
C Guarino, M Legowska, C Epinette, C Kellenberger, S Dallet-Choisy, ...
Journal of Biological Chemistry 289 (46), 31777-31791, 2014
322014
Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
M Krochmal, G Kontostathi, P Magalhães, M Makridakis, J Klein, H Husi, ...
Scientific reports 7 (1), 1-11, 2017
312017
Analytical performance of ELISA assays in urine: one more bottleneck towards biomarker validation and clinical implementation
D Chatziharalambous, V Lygirou, A Latosinska, K Stravodimos, A Vlahou, ...
PloS one 11 (2), e0149471, 2016
282016
Proteomic analysis of normal and cancer cervical cell lines reveals deregulation of cytoskeleton-associated proteins
KI Pappa, V Lygirou, G Kontostathi, J Zoidakis, M Makridakis, K Vougas, ...
Cancer Genomics & Proteomics 14 (4), 253-266, 2017
272017
Proteome‐based classification of Nonmuscle Invasive Bladder Cancer
R Stroggilos, M Mokou, A Latosinska, M Makridakis, V Lygirou, ...
International Journal of Cancer 146 (1), 281-294, 2020
232020
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20